Short answer
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed its Q3 2025 10-Q quarterly report on Nov 7, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $497M (up 50.1% year over year) with net income of −$14M.
Q3 2025 key financials · XBRL
- Revenue
- $497M
- +50.1% YoY · +4.0% QoQ
- Net income
- −$14M
- +16.7% YoY · −48.3% QoQ
- Operating margin
- -4.9%
Source: XBRL data from the CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) Q3 2025 10-Q on SEC EDGAR. USD.
CLOVER HEALTH INVESTMENTS, CORP. /DE Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No new or updated risk factors disclosed this quarter from 2024 Form 10-K risks
- Regulatory risk: ongoing compliance with evolving healthcare laws and potential Medicaid/Medicare reimbursement changes
- Operational risk: dependence on data analytics accuracy for member outcomes and cost management
- Market risk: competitive pressure from larger health insurers impacting membership growth and retention
- Financial risk: liquidity management critical due to net losses and reliance on capital markets for funding
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CLOVER HEALTH INVESTMENTS, CORP. /DE quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.